CClinicalTrials.gg
CompletedNCT05436262Updated Jan 8, 2025Results posted

Using Real-time fMRI Neurofeedback and Motor Imagery to Enhance Motor Timing and Precision in Cerebellar Ataxia

An interventional study of Real-time fMRI with neurofeedback of motor imagery in Cerebellar Ataxia, Spinocerebellar Ataxias and Cerebellar Degeneration, sponsored by Johns Hopkins University. Completed at 1 site in United States. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2025-01-08.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

The aim of the research is to improve motor function in people with cerebellar ataxia by using neuroimaging methods and mental imagery to "exercise" motor networks in the brain. The relevance of this research to public health is that results have the potential to reduce motor deficits associated with cerebellar atrophy, thereby enhancing the quality of life and promoting independence.

02

Conditions studied

  • Cerebellar Ataxia
  • Spinocerebellar Ataxias
  • Cerebellar Degeneration

Keywords

  • Cerebellar Ataxia
  • Spinocerebellar Ataxias
  • Cerebellar Diseases
  • Neurodegenerative Diseases
  • Cerebellum
  • Gait
  • Balance
  • Movement Disorders
03

In context

Ataxia

295 studies on the registry are indexed under Ataxia; 51 are open to participants now.

This study's enrollment of 21 is below the median of 26 across 216 interventional studies indexed under Ataxia.

Browse Ataxia studies →

Lead sponsor

Johns Hopkins University is the lead sponsor of 1,783 studies on the registry; 313 are open to participants now.

Of its 203 completed or terminated interventional studies of FDA-regulated products, 140 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18-100 years of age
  • At least 8th-grade education
  • Right-handedness
  • Clinical diagnosis of progressive, degenerative cerebellar ataxia by a movement disorder specialist (cerebellar ataxia of unknown etiology, and spinocerebellar ataxias with and without genetic confirmation)

Exclusion criteria

Exclusion Criteria:

  • History of Axis I psychiatric disorders (including alcohol and drug dependence)
  • Severe or unstable medical disorder, neurological disorders, such as stroke or epilepsy
  • History of head injury that resulted in a loss of consciousness greater than 5 minutes and/or neurological sequelae
  • Any condition that is contraindicated for the MRI environment (e.g., metal in the body, pacemaker, claustrophobia)
  • Currently pregnant
  • Clinical diagnosis of multiple system atrophy (MSA) or Friedrich's ataxia (FA)
  • Eligible subjects may be asked to refrain from medications that affect the central nervous system that would also make data difficult to interpret (e.g., sedatives) for an appropriate period of time prior to scanning
  • Participants will be excluded if the participants do not have a home computer with internet available to complete the 3-week at-home component of the study protocol
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
21 participants (actual)

Study arms

  • Experimental
    Real time neurofeedback with task and at-home finger tapping practice sessions

    Participants will undergo a real-time fMRI scan during which two distinct tasks will be performed. Neurofeedback treatment: During the fMRI scan, the tasks consist of: 1. Overt finger tapping in time with a flashing cue. 2. Motor imagery (of finger tapping). During overt finger tapping, feedback will consist of a slider bar that indicates tapping accuracy to target speed (1 or 4Hz). During motor imagery, neurofeedback will consist of a crosshair that flashes to indicate the success of recruiting predicted brain regions (consistent with those engaged during overt tapping). At-home therapy: Participants are assigned to one of two groups where participants will practice each day 17 sessions total at-home. Group 1: Overt finger tapping on 17 daily sessions. Participants will finger tap in time with the flashing cue.

    Device: Real-time fMRI with neurofeedback of motor imagery

  • Experimental
    Real time neurofeedback with task and at-home motor imagery practice sessions

    Participants will undergo a real-time fMRI scan during which two distinct tasks will be performed. Neurofeedback treatment: During the fMRI scan, the tasks consist of: 1. Overt finger tapping in time with a flashing cue. 2. Motor imagery (of finger tapping). During overt finger tapping, feedback will consist of a slider bar that indicates tapping accuracy to target speed (1 or 4Hz). During motor imagery, neurofeedback will consist of a crosshair that flashes to indicate the success of recruiting predicted brain regions (consistent with those engaged during overt tapping). At-home therapy: Participants are assigned to one of two groups where participants will practice each day 17 sessions total at-home. Group 2: Motor imagery only on 13 daily sessions, and overt finger tapping only on 4 daily sessions.

    Device: Real-time fMRI with neurofeedback of motor imagery

Interventions

  • DeviceReal-time fMRI with neurofeedback of motor imagery

    Participants undergo a real-time fMRI scan during which they are provided feedback regarding the accuracy of their motor imagery performance.

06

What researchers measure

Primary outcomes

  1. Change in Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 1Hz Speed

    During the MRI session, accuracy on overt tapping will be measured by the distance of the actual tapping rate vs. target rate (1Hz). Accuracy at baseline will be compared to that of final assessment, which will take place before and after neurofeedback training, respectively. The difference in accuracy between the two tests create a delta measure (i.e., fewer errors in the final vs. baseline tests). This delta accuracy will indicate the magnitude of tapping accuracy improvements. Root mean squared error (RMSE) is the measure for both the baseline and post-treatment behavioral tasks. RMSE will be based on the actual number of taps per second relative to the expected number of taps per second (e.g., 1 tap for 1Hz). Then post treatment RMSE minus baseline RMSE will determine a delta RMSE. A higher RMSE signifies greater error. For the delta measure, it is expected, lower scores reflect greater improvement on the task.

    Time frame: Baseline and MRI duration, up to 1 hour

  2. Change in Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 4Hz Speed

    During the MRI session, accuracy on overt tapping will be measured by the distance of the actual tapping rate vs. target rate (4Hz). Accuracy at baseline will be compared to that of final assessment, which will take place before and after neurofeedback training, respectively. The difference in accuracy between the two tests create a delta measure (i.e., fewer errors in the final vs. baseline tests). This delta accuracy will indicate the magnitude of tapping accuracy improvements. Root mean squared error (RMSE) is the measure for both the baseline and post-treatment behavioral tasks. RMSE will be based on the actual number of taps per second relative to the expected number of taps per second (e.g., 1 tap for 1Hz). Then post treatment RMSE minus baseline RMSE will determine a delta RMSE. A higher RMSE signifies greater error. For the delta measure, it is expected, lower scores reflect greater improvement on the task.

    Time frame: Baseline and MRI duration, up to 1 hour

  3. Change in At-home Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 1Hz Speed

    Accuracy at baseline will be compared to that of final assessment, which will take place before and after the 3-week at-home practice sessions, respectively. The delta measure will indicate the magnitude of tapping accuracy improvements. Groups will be compared to examine differences in delta as a function of practice condition (tapping only or imagery plus tapping). RMSE (root mean squared error) is the measure for both the baseline and post-treatment behavioral tasks. RMSE will be based on the actual number of taps per second relative to the expected number of taps per second (e.g., 1 tap for 1Hz). Then post treatment RMSE minus baseline RMSE will determine a delta RMSE. A higher RMSE signifies greater error. For the delta measure, it is expected, lower scores reflect greater improvement on the task.

    Time frame: Baseline and At-home sessions (10 minutes/day), up to 23 days

  4. Change in At-home Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 4Hz Speed

    Accuracy at baseline will be compared to that of final assessment, which will take place before and after the 3-week at-home practice sessions, respectively. The delta measure will indicate the magnitude of tapping accuracy improvements. Groups will be compared to examine differences in delta as a function of practice condition (tapping only or imagery plus tapping). RMSE (root mean squared error) is the measure for both the baseline and post-treatment behavioral tasks. RMSE will be based on the actual number of taps per second relative to the expected number of taps per second (e.g., 4 taps for 4Hz). Then post treatment RMSE minus baseline RMSE will determine a delta RMSE. A higher RMSE signifies greater error. For the delta measure, it is expected, lower scores reflect greater improvement on the task.

    Time frame: Baseline and At-home sessions (10 minutes/day), up to 23 days

Secondary outcomes

  1. The Correlation Between MRI BOLD During Imagery and Finger Tapping Accuracy Improvements to a Flashing Cue at 1Hz as Assessed by a Correlation Coefficient

    This will assess the correlation between MRI Blood Oxygen Level Dependence (BOLD) during imagery and finger tapping accuracy improvement (pre- vs. post- neurofeedback training) by a correlation coefficient. The correlation coefficient ranging from -1 to 1, where the closer the coefficient is to -1 indicates a negative association and the closer the coefficient is to 1 indicates a strong positive association.

    Time frame: MRI duration, up to 1 hour

  2. The Correlation Between MRI BOLD and Finger Tapping Accuracy to a Flashing Cue at 4Hz as Assessed by a Correlation Coefficient

    This will assess the correlation between MRI Blood Oxygen Level Dependence (BOLD) during imagery and finger tapping accuracy improvement (pre- vs. post- neurofeedback training) by a correlation coefficient. The correlation coefficient ranging from -1 to 1, where the closer the coefficient is to -1 indicates a negative association and the closer the coefficient is to 1 indicates a strong positive association.

    Time frame: MRI duration, up to 1 hour

  3. The Correlation Between the KVIQ and Imagery Accuracy of the Flashing Cross on the MRI Task as Assessed by a Correlation Coefficient

    The Kinesthetic and Visual Imagery Questionnaire (KVIQ), overall score ranging from 0-100, where higher scores reflect more vivid imagery) will assess imagery vividness. This will be correlated with the image accuracy measures described in Secondary Outcome Measure 5. The correlation coefficient ranging from -1 to 1, where the closer the coefficient is to -1 indicates a negative association and the closer the coefficient is to 1 indicates a strong positive association.

    Time frame: Up to 1.5 hours

  4. The Correlation Between the ICARS and Imagery Accuracy Accuracy of the Flashing Cross on the MRI Task as Assessed by a Correlation Coefficient

    The International Cooperative Ataxia Rating Scale (ICARS), overall score ranging from 0-100, where higher scores indicate more severe neurological impairment) will assess neurological impairments. This will be correlated with image accuracy measures described in 'Secondary Outcome Measure 5. The correlation coefficient ranging from -1 to 1, where the closer the coefficient is to -1 indicates a negative association and the closer the coefficient is to 1 indicates a strong positive association.

    Time frame: Up to 1.5 hours

07

Results

Posted Jan 8, 2025

Participant flow

Pre-Randomization
Participant flow — Pre-Randomization
MilestonePre-Randomization: fMRI NeurofeedbackRandomization: Homework Sessions With Tapping Only (Control Group)Randomization: Homework Sessions With Imagery Only (Intervention Group)
Started2100
Completed2000
Not completed100
Withdrew: Withdrawal by subject100
Randomization
Participant flow — Randomization
MilestonePre-Randomization: fMRI NeurofeedbackRandomization: Homework Sessions With Tapping Only (Control Group)Randomization: Homework Sessions With Imagery Only (Intervention Group)
Started0119
Completed0109
Not completed010
Withdrew: Withdrawal by subject010

Outcome measures

PrimaryChange in Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 1Hz Speed

During the MRI session, accuracy on overt tapping will be measured by the distance of the actual tapping rate vs. target rate (1Hz). Accuracy at baseline will be compared to that of final assessment, which will take place before and after neurofeedback training, respectively. The difference in accuracy between the two tests create a delta measure (i.e., fewer errors in the final vs. baseline tests). This delta accuracy will indicate the magnitude of tapping accuracy improvements. Root mean squared error (RMSE) is the measure for both the baseline and post-treatment behavioral tasks. RMSE will be based on the actual number of taps per second relative to the expected number of taps per second (e.g., 1 tap for 1Hz). Then post treatment RMSE minus baseline RMSE will determine a delta RMSE. A higher RMSE signifies greater error. For the delta measure, it is expected, lower scores reflect greater improvement on the task.

Time frame:
Baseline and MRI duration, up to 1 hour
Reported as:
Mean · taps per second
Change in Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 1Hz Speed
taps per secondPre-Randomization: fMRI Neurofeedback
Change in Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 1Hz Speed.00141488 ± .007294434
PrimaryChange in Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 4Hz Speed

During the MRI session, accuracy on overt tapping will be measured by the distance of the actual tapping rate vs. target rate (4Hz). Accuracy at baseline will be compared to that of final assessment, which will take place before and after neurofeedback training, respectively. The difference in accuracy between the two tests create a delta measure (i.e., fewer errors in the final vs. baseline tests). This delta accuracy will indicate the magnitude of tapping accuracy improvements. Root mean squared error (RMSE) is the measure for both the baseline and post-treatment behavioral tasks. RMSE will be based on the actual number of taps per second relative to the expected number of taps per second (e.g., 1 tap for 1Hz). Then post treatment RMSE minus baseline RMSE will determine a delta RMSE. A higher RMSE signifies greater error. For the delta measure, it is expected, lower scores reflect greater improvement on the task.

Time frame:
Baseline and MRI duration, up to 1 hour
Reported as:
Mean · taps per second
Change in Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 4Hz Speed
taps per secondPre-Randomization: fMRI Neurofeedback
Change in Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 4Hz Speed.00165387 ± .010581808
PrimaryChange in At-home Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 1Hz Speed

Accuracy at baseline will be compared to that of final assessment, which will take place before and after the 3-week at-home practice sessions, respectively. The delta measure will indicate the magnitude of tapping accuracy improvements. Groups will be compared to examine differences in delta as a function of practice condition (tapping only or imagery plus tapping). RMSE (root mean squared error) is the measure for both the baseline and post-treatment behavioral tasks. RMSE will be based on the actual number of taps per second relative to the expected number of taps per second (e.g., 1 tap for 1Hz). Then post treatment RMSE minus baseline RMSE will determine a delta RMSE. A higher RMSE signifies greater error. For the delta measure, it is expected, lower scores reflect greater improvement on the task.

Time frame:
Baseline and At-home sessions (10 minutes/day), up to 23 days
Reported as:
Mean · taps per second
Change in At-home Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 1Hz Speed
taps per secondRandomization: Homework Sessions With Tapping Only (Control Group)Randomization: Homework Sessions With Imagery Only (Intervention Group)
Change in At-home Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 1Hz Speed.392919831 ± .6227685278.200339199 ± .3242518927
PrimaryChange in At-home Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 4Hz Speed

Accuracy at baseline will be compared to that of final assessment, which will take place before and after the 3-week at-home practice sessions, respectively. The delta measure will indicate the magnitude of tapping accuracy improvements. Groups will be compared to examine differences in delta as a function of practice condition (tapping only or imagery plus tapping). RMSE (root mean squared error) is the measure for both the baseline and post-treatment behavioral tasks. RMSE will be based on the actual number of taps per second relative to the expected number of taps per second (e.g., 4 taps for 4Hz). Then post treatment RMSE minus baseline RMSE will determine a delta RMSE. A higher RMSE signifies greater error. For the delta measure, it is expected, lower scores reflect greater improvement on the task.

Time frame:
Baseline and At-home sessions (10 minutes/day), up to 23 days
Reported as:
Mean · taps per second
Change in At-home Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 4Hz Speed
taps per secondRandomization: Homework Sessions With Tapping Only (Control Group)Randomization: Homework Sessions With Imagery Only (Intervention Group)
Change in At-home Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 4Hz Speed.35613192 ± .7481023854.067492801 ± .5086197309
SecondaryThe Correlation Between MRI BOLD During Imagery and Finger Tapping Accuracy Improvements to a Flashing Cue at 1Hz as Assessed by a Correlation Coefficient

This will assess the correlation between MRI Blood Oxygen Level Dependence (BOLD) during imagery and finger tapping accuracy improvement (pre- vs. post- neurofeedback training) by a correlation coefficient. The correlation coefficient ranging from -1 to 1, where the closer the coefficient is to -1 indicates a negative association and the closer the coefficient is to 1 indicates a strong positive association.

Time frame:
MRI duration, up to 1 hour
Reported as:
Number · correlation coefficient
The Correlation Between MRI BOLD During Imagery and Finger Tapping Accuracy Improvements to a Flashing Cue at 1Hz as Assessed by a Correlation Coefficient
correlation coefficientPre-Randomization: fMRI Neurofeedback
Left Crus II cerebellum.850
Right Posterior Insula.861
Right Inferior Frontal Gyrus.838
Left Posterior Insula.842
Left Internal Capsule.884
Right Ventral Caudate.850
SecondaryThe Correlation Between MRI BOLD and Finger Tapping Accuracy to a Flashing Cue at 4Hz as Assessed by a Correlation Coefficient

This will assess the correlation between MRI Blood Oxygen Level Dependence (BOLD) during imagery and finger tapping accuracy improvement (pre- vs. post- neurofeedback training) by a correlation coefficient. The correlation coefficient ranging from -1 to 1, where the closer the coefficient is to -1 indicates a negative association and the closer the coefficient is to 1 indicates a strong positive association.

Time frame:
MRI duration, up to 1 hour
Reported as:
Number · correlation coefficient
The Correlation Between MRI BOLD and Finger Tapping Accuracy to a Flashing Cue at 4Hz as Assessed by a Correlation Coefficient
correlation coefficientPre-Randomization: fMRI Neurofeedback
The Correlation Between MRI BOLD and Finger Tapping Accuracy to a Flashing Cue at 4Hz as Assessed by a Correlation Coefficient.688
SecondaryThe Correlation Between the KVIQ and Imagery Accuracy of the Flashing Cross on the MRI Task as Assessed by a Correlation Coefficient

The Kinesthetic and Visual Imagery Questionnaire (KVIQ), overall score ranging from 0-100, where higher scores reflect more vivid imagery) will assess imagery vividness. This will be correlated with the image accuracy measures described in Secondary Outcome Measure 5. The correlation coefficient ranging from -1 to 1, where the closer the coefficient is to -1 indicates a negative association and the closer the coefficient is to 1 indicates a strong positive association.

Time frame:
Up to 1.5 hours
Reported as:
Number · correlation coefficient
The Correlation Between the KVIQ and Imagery Accuracy of the Flashing Cross on the MRI Task as Assessed by a Correlation Coefficient
correlation coefficientPre-Randomization: fMRI Neurofeedback
The Correlation Between the KVIQ and Imagery Accuracy of the Flashing Cross on the MRI Task as Assessed by a Correlation Coefficient.953
SecondaryThe Correlation Between the ICARS and Imagery Accuracy Accuracy of the Flashing Cross on the MRI Task as Assessed by a Correlation Coefficient

The International Cooperative Ataxia Rating Scale (ICARS), overall score ranging from 0-100, where higher scores indicate more severe neurological impairment) will assess neurological impairments. This will be correlated with image accuracy measures described in 'Secondary Outcome Measure 5. The correlation coefficient ranging from -1 to 1, where the closer the coefficient is to -1 indicates a negative association and the closer the coefficient is to 1 indicates a strong positive association.

Time frame:
Up to 1.5 hours
Reported as:
Number · correlation coefficient
The Correlation Between the ICARS and Imagery Accuracy Accuracy of the Flashing Cross on the MRI Task as Assessed by a Correlation Coefficient
correlation coefficientPre-Randomization: fMRI Neurofeedback
The Correlation Between the ICARS and Imagery Accuracy Accuracy of the Flashing Cross on the MRI Task as Assessed by a Correlation Coefficient-.263

Adverse events

Collected over Up To 3 Weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Pre-Randomization: fMRI Neurofeedback0/21 (0%)0/21 (0%)0/21 (0%)
fMRI Neurofeedback and Homework Sessions With Tapping (Control Group)0/11 (0%)0/11 (0%)0/11 (0%)
fMRI Neurofeedback and Homework Sessions With Imagery (Intervention Group)0/9 (0%)0/9 (0%)0/9 (0%)

Baseline characteristics

All participants have cerebellar ataxia.

Age, Continuous
Age, Continuous(years)Real Time Neurofeedback With Task With At-home Practice Sessions
Mean58.31 ± 11.69
Sex: Female, Male
Sex: Female, Male(Participants)Real Time Neurofeedback With Task With At-home Practice Sessions
Female11
Male10
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Real Time Neurofeedback With Task With At-home Practice Sessions
Hispanic or Latino1
Not Hispanic or Latino20
Unknown or Not Reported0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Real Time Neurofeedback With Task With At-home Practice Sessions
American Indian or Alaska Native0
Asian1
Native Hawaiian or Other Pacific Islander0
Black or African American5
White14
More than one race1
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(Participants)Real Time Neurofeedback With Task With At-home Practice Sessions
United States20
United Kingdom1
International Cooperative Ataxia Rating Scale (ICARS)
International Cooperative Ataxia Rating Scale (ICARS)(units on a scale)Real Time Neurofeedback With Task With At-home Practice Sessions
Mean35.43 ± 19.36
Kinesthetic and Visual Imagery Questionnaire (KVIQ)
Kinesthetic and Visual Imagery Questionnaire (KVIQ)(units on a scale)Real Time Neurofeedback With Task With At-home Practice Sessions
Mean38.00 ± 9.24
08

Study locations

1 site
  • Johns Hopkins University School of Medicine
    Baltimore, Maryland 21205, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Jul 21, 2023
  • Informed consent form · Aug 13, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

Supporting information: Study protocol, Sap

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05436262
Lead sponsor
Johns Hopkins University
Collaborators
Virginia Polytechnic Institute and State University, National Institute of Neurological Disorders and Stroke (NINDS)
Responsible party
Sponsor
First posted
Jun 29, 2022
Start date
Mar 14, 2023
Primary completion
Jan 22, 2024
Completion
Jan 22, 2024
Results posted
Jan 8, 2025
Last update
Jan 8, 2025

Study contacts

Cherie Marvel, PhD
principal investigator · Johns Hopkins University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion